Ads
related to: thalidomide for multiple myeloma treatment- Recent Myeloma Research
Explore Recent Findings
in Myeloma Research
- Transform Myeloma
Multiple Myeloma Information
and Resources for HCPs
- Frontline MM Landscape
Evolving 1st-Line MM Care
Towards Improved Outcomes
- Patient Factors & Impacts
Optimal Management
Review the Critical Factors
- Recent Myeloma Research
alternativebee.com has been visited by 10K+ users in the past month
benchmarkguide.com has been visited by 10K+ users in the past month
explorefrog.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Thalidomide is used as a first-line treatment for multiple myeloma in combination with dexamethasone or with melphalan and prednisone to treat acute episodes of erythema nodosum leprosum, as well as for maintenance therapy. [14] [15] The bacterium that causes tuberculosis (TB) is related to leprosy.
The problems with thalidomide included teratogenic side effects, high incidence of other adverse reactions, poor solubility in water and poor absorption from the intestines. In 1998 thalidomide was approved by the U.S. Food and Drug Administration (FDA) for use in newly diagnosed multiple myeloma (MM) under strict regulations. [2]
A 2016 study concluded that stem cell transplant is the preferred treatment for multiple myeloma. [107] There are two types of stem cell transplants to treat multiple myeloma. [108] In autologous hematopoietic stem-cell transplantation (ASCT) – the patient's stem cells are collected from the patient's blood. The patient is given high-dose ...
DT-PACE refers to a chemotherapy regimen for multiple myeloma consisting of Dexamethasone, Thalidomide, Cisplatin or Platinol, Adriamycin or doxorubicin, Cyclophosphamide, and Etoposide. [ 1 ] References
thalidomide: acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (ENL) and maintenance therapy for prevention and suppression of the cutaneous manifestations of ENL recurrences 07-16-1998 Thalomid: thalidomide (in combination with dexamethasone) treatment of patients with newly diagnosed multiple myeloma
Thalidomide: PO: As above. Multiple myeloma, erythema nodosum leprosum and the following orphan indications: graft versus host disease, mycobacterial infection, recurrent aphthous ulcers, severe recurrent aphthous stomatitis, primary brain malignancies, HIV-associated wasting syndrome, Crohn's disease, Kaposi's sarcoma, myelodysplastic syndrome ...
Ads
related to: thalidomide for multiple myeloma treatmentalternativebee.com has been visited by 10K+ users in the past month
benchmarkguide.com has been visited by 10K+ users in the past month
explorefrog.com has been visited by 10K+ users in the past month